Entero Therapeutics, Inc. (ENTO) — Financial Flexibility Index
Entero Therapeutics, Inc. (ENTO) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of $-855.69K (operating CF $-855.69K minus capex $0.00) represents 0% of total liabilities ($45.81 Million). Also explore ENTO net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Entero Therapeutics, Inc. Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Entero Therapeutics, Inc. across 12 annual periods. Check Entero Therapeutics, Inc. (ENTO) asset resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Entero Therapeutics, Inc. (2013–2024)
Year-by-year free cash flow to debt coverage for Entero Therapeutics, Inc.. For the full company profile including market capitalisation, see Entero Therapeutics, Inc. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.33x | $-9.22 Million | $-9.22 Million | $27.61 Million | ▲ +90.8% |
| 2023 | -3.62x | $-11.88 Million | $-12.38 Million | $3.28 Million | ▲ +56.3% |
| 2022 | -8.28x | $-22.34 Million | $-22.34 Million | $2.70 Million | ▼ -639.4% |
| 2021 | -1.12x | $-21.97 Million | $-32.29 Million | $19.61 Million | ▼ -55.4% |
| 2020 | -0.72x | $-11.22 Million | $-11.22 Million | $15.56 Million | ▼ -30788.6% |
| 2019 | 0.00x | $10.06K | $-14.03K | $4.29 Million | ▲ +100.1% |
| 2018 | -3.53x | $-10.56 Million | $-10.87 Million | $3.00 Million | ▼ -88.3% |
| 2017 | -1.87x | $-7.15 Million | $-7.18 Million | $3.82 Million | ▼ -46.6% |
| 2016 | -1.28x | $-4.52 Million | $-4.53 Million | $3.54 Million | ▼ -317695.5% |
| 2015 | 0.00x | $-4.15K | $-4.17K | $10.32 Million | ▼ -92.3% |
| 2014 | 0.00x | $-821.39 | $-1.01K | $3.93 Million | ▼ -100.3% |
| 2013 | 0.06x | $56.55 | $56.55 | $939.30 | — |